Drugs & Therapy Perspectives

, Volume 23, Issue 7, pp 21–23 | Cite as

Inhaled corticosteroids appear to have little risk of causing adverse effects on growth, bdbone density or cortisol levels in children with asthma

Drug Reactions and Interaction


  1. 1.
    Pedersen S. Clinical safety of inhaled corticosteroids for asthma in children: an update of long-term trials. Drug Saf 2006: 29(7): 599–612PubMedCrossRefGoogle Scholar
  2. 2.
    Price JF, Russell G, Hindmarsh PC, et al. Growth during one year of treatment with fluticasone propionate or sodium cromoglycate in children with asthma. Pediatr Pulmonol 1997; 24: 178–86PubMedCrossRefGoogle Scholar
  3. 3.
    Bisgaard H, Allen D, Milanowski J, et al. Twelve-month safety and efficacy of inhaled fluticasone propionate in children aged 1 to 3 years with recurrent wheezing. Pediatrics 2004; 113: e87–94PubMedCrossRefGoogle Scholar
  4. 4.
    Merkus PJ, van Essen-Zandvliet EE, Duiverman EJ, et al. Long-term effect of inhaled corticosteroids on growth rate in adolescents with asthma. Pediatrics 1993; 91: 1121–6PubMedGoogle Scholar
  5. 5.
    Tinkelman DG, Reed CE, Nelson HS, et al. Aerosol beclometasone compared with theophylline as primary treatment of chronic, mild to moderately severe asthma in children. Pediatrics 1993; 92: 64–77PubMedGoogle Scholar
  6. 6.
    Rao R, Gregson RK, Jones AC, et al. Systemic effects of inhaled corticosteroids on growth and bone turnover in childhood asthma: a comparison of fluticasone with beclomethasone. Eur Respir J 1999; 13: 87–94PubMedCrossRefGoogle Scholar
  7. 7.
    Allen DB, Bronsky EA, LaForce CF, et al. Growth in asthmatic children treated with fluticasone propionate. Fluticasone Propionate Asthma Study Group. J Pediatr 1998; 132: 472–7PubMedCrossRefGoogle Scholar
  8. 8.
    Roux C, Kolta S, Desfougeres JL, et al. Long-term safety of fluticasone propionate and nedocromil sodium on bone in children with asthma. Pediatrics 2003; 111: e706–13PubMedCrossRefGoogle Scholar
  9. 9.
    Jonasson G, Carlsen KH, Jonasson C, et al. Low-dose inhaled budesonide once or twice daily for 27 months in children with mild asthma. Allergy 2000; 55: 740–8PubMedCrossRefGoogle Scholar
  10. 10.
    Bacharier LB, Raissy HH, Wilson L, et al. Long-term effect of budesonide on hypothalamic-pituitary-adrenal axis function in children with mild to moderate asthma. Pediatrics 2004; 113: 1693–9PubMedCrossRefGoogle Scholar
  11. 11.
    Childhood Asthma Management Program Research Group. Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med 2000; 343: 1054–63CrossRefGoogle Scholar
  12. 12.
    Verberne AA, Frost C, Roorda RJ, et al. One year treatment with salmeterol compared with beclomethasone in children with asthma. The Dutch Paediatric Asthma Study Group. Am J Respir Crit Care Med 1997; 156: 688–95PubMedGoogle Scholar
  13. 13.
    Simons FE. A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group. N Engl J Med 1997; 337: 1659–65PubMedCrossRefGoogle Scholar
  14. 14.
    Visser MJ, van der Veer E, Postma DS, et al. Side-effects of fluticasone in asthmatic children: no effects after dose reduction. Eur Respir J 2004; 24: 420–5PubMedCrossRefGoogle Scholar
  15. 15.
    Verona E, Petrov D, Cserhati E, et al. Fluticasone propionate in asthma: a long term dose comparison study. Arch Dis Child 2003; 88: 503–9PubMedCrossRefGoogle Scholar
  16. 16.
    de Benedictis FM, Teper A, Green RJ, et al. Effects of 2 inhaled corticosteroids on growth: results of a randomized controlled trial. Arch Pediatr Adolesc Med 2001; 155: 1248–54PubMedGoogle Scholar
  17. 17.
    Skoner DP, Szefler SJ, Welch M, et al. Longitudinal growth in infants and young children treated with budesonide inhalation suspension for persistent asthma. J Allergy Clin Immunol 2000; 105: 259–68PubMedCrossRefGoogle Scholar
  18. 18.
    Scott MB, Skoner DP. Short-term and long-term safety of budesonide inhalation suspension in infants and young children with persistent asthma. J Allergy Clin Immunol 1999; 104: 200–9PubMedCrossRefGoogle Scholar
  19. 19.
    Leflein JG, Szefler SJ, Murphy KR, et al. Nebulized budesonide inhalation suspension compared with cromolyn sodium nebulizer solution for asthma in young children: results of a randomized outcomes trial. Pediatrics 2002; 109: 866–72PubMedCrossRefGoogle Scholar
  20. 20.
    Pedersen S. Do inhaled corticosteroids inhibit growth in children? Am J Respir Crit Care Med 2001; 164: 521–35PubMedGoogle Scholar
  21. 21.
    Agertoft L, Pedersen S. Effect of long-term treatment with inhaled budesonide on adult height in children with asthma. N Engl J Med 2000; 343: 1064–9PubMedCrossRefGoogle Scholar
  22. 22.
    Larsson L, Gerhardsson de Verdier M, Lindmark B, et al. Budesonide-treated asthmatic adolescents attain target height: a population-based follow-up study from Sweden. Pharmacoepidemiol Drug Saf 2002; 11: 715–20PubMedCrossRefGoogle Scholar
  23. 23.
    Inoue T, Doi S, Takamatsu I, et al. Effect of long-term treatment with inhaled beclometasone on growth of asthmatic children. J Asthma 1999; 36: 159–64PubMedCrossRefGoogle Scholar
  24. 24.
    Silverstein MD, Yunginger JW, Reed CE, et al. Attained adult height after childhood asthma: effect of glucocorticoid therapy. J Allergy Clin Immunol 1997; 99: 466–74PubMedCrossRefGoogle Scholar
  25. 25.
    Van Bever HP, Desager KN, Lijssens N, et al. Does treatment of asthmatic children with inhaled corticosteroids affect their adult height? Pediatr Pulmonol 1999; 27: 369–75PubMedCrossRefGoogle Scholar
  26. 26.
    Norjavaara E, Gerhardsson De Verdier M, Lindmark B. Reduced height in Swedish men with asthma at the age of conscription for military service. J Pediatr 2000; 137: 25–9PubMedCrossRefGoogle Scholar
  27. 27.
    Schlienger RG, Jick SS, Meier CR. Inhaled corticosteroids and the risk of fractures in children and adolescents. Pediatrics 2004; 114: 469–73PubMedCrossRefGoogle Scholar
  28. 28.
    van Staa TP, Bishop N, Leufkens HG, et al. Are inhaled corticosteroids associated with an increased risk of fracture in children? Osteoporos Int 2004; 15: 785–91PubMedCrossRefGoogle Scholar
  29. 29.
    Todd GR, Acerini CL, Ross-Russell R, et al. Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom. Arch Dis Child 2002; 87: 457–61PubMedCrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2007

Personalised recommendations